Taletrectinib for the treatment of ROS-1 positive non-small cell lung cancer: a drug evaluation of phase I and II data
Article in Expert Opinion on Investigational Drugs (January 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in Expert Opinion on Investigational Drugs (January 2024)
Book chapter (February 2023)
Article in Pharmacology & Therapeutics (January 2023)